Berkeley Lights to Participate in Cowen 42nd Annual Health Care Conference
Berkeley Lights, Inc. (Nasdaq: BLI) announced its participation in the Cowen 42nd Annual Health Care Conference, occurring virtually from March 7-9, 2022. Eric Hobbs, Ph.D., CEO, will join the Synthetic Biology Enabling Technologies Panel on March 7 at 10:30 a.m. ET. Furthermore, management will present in a fireside chat on March 8 at 12:50 p.m. ET. Interested parties can access the live broadcast through the company’s website.
- None.
- None.
EMERYVILLE, Calif., Feb. 28, 2022 (GLOBE NEWSWIRE) -- Berkeley Lights, Inc. (Nasdaq: BLI), a leader in digital cell biology, today announced the Company will participate in the Cowen 42nd Annual Health Care Conference, taking place virtually March 7-9, 2022.
- Eric Hobbs, Ph.D., chief executive officer of Berkeley Lights, will participate on the Synthetic Biology Enabling Technologies Panel on Monday, March 7 at 10:30 a.m. – 11:30 a.m. Eastern Time.
- Berkeley Lights management will present in a fireside chat on Tuesday, March 8 at 12:50 p.m. – 1:20 p.m. Eastern Time.
Interested parties may access the live webcast of the panel and fireside chat presentation through a link on the “Investors” section of the company website at: www.berkeleylights.com.
About Berkeley Lights
Berkeley Lights is a leading digital cell biology company focused on enabling and accelerating the rapid development and commercialization of biotherapeutics and other cell-based products for our customers. The Berkeley Lights Platform captures deep phenotypic, functional and genotypic information for thousands of single cells in parallel and can also deliver the live biology customers desire in the form of the best cells. Our platform is a fully integrated, end-to-end solution, comprising proprietary consumables, including our OptoSelect™ chips and reagent kits, advanced automation systems, and application software. We developed the Berkeley Lights Platform to provide the most advanced environment for rapid functional characterization of single cells at scale, the goal of which is to establish an industry standard for our customers throughout their cell-based product value chain.
Berkeley Lights’ Beacon® and Lightning™ systems and Culture Station™ instrument are FOR RESEARCH USE ONLY. Not for use in diagnostic procedures.
Forward-Looking Statements
To the extent that statements contained in this press release are not descriptions of historical facts regarding Berkeley Lights or its products, they are forward-looking statements reflecting the current beliefs and expectations of management. Such forward-looking statements involve substantial known and unknown risks and uncertainties that relate to future events, and actual results and product performance could differ significantly from those expressed or implied by the forward-looking statements. Berkeley Lights undertakes no obligation to update or revise any forward-looking statements. For a further description of the risks and uncertainties relating to the Company’s growth and continual evolution see the statements in the "Risk Factors" sections, and elsewhere, in our filings with the U.S. Securities and Exchange Commission.
Investor Contact
IR@berkeleylights.com
Media Contact
Media@berkeleylights.com
FAQ
What event will Berkeley Lights participate in March 2022?
When is Eric Hobbs speaking at the Cowen Conference?
When will the fireside chat by Berkeley Lights management occur?
How can I access Berkeley Lights' conference presentations?
What is the stock symbol for Berkeley Lights?
